+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "B Cell Maturation Antigen"

B-Cell Maturation Antigen Targeted Therapies - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

B-Cell Maturation Antigen Targeted Therapies - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025 - Product Thumbnail Image

Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 450 Pages
  • Global
From
CAR T-cell Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

CAR T-cell Therapy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CAR-T - Pipeline Insight, 2025 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
CAR T-Cell Therapy For Multiple Myeloma - Pipeline Insight, 2025 - Product Thumbnail Image

CAR T-Cell Therapy For Multiple Myeloma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Cancer Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Cancer Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
Biologics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Biologics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 100 Pages
  • Global
From
CAR-T Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

CAR-T Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • June 2024
  • 182 Pages
  • Global
From
Cell Based Immunotherapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Thumbnail Image

Cell Based Immunotherapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • April 2025
  • 110 Pages
  • Global
From
Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis - Product Thumbnail Image

Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

  • Report
  • July 2022
  • 263 Pages
  • Global
From
GPRC5D-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis - Product Thumbnail Image

GPRC5D-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

  • Report
  • July 2022
  • 60 Pages
  • Global
From
Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026 - Product Thumbnail Image

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026

  • Report
  • November 2021
  • 222 Pages
  • Global
From
Cellular Immunotherapy Market Size, Share & Trends Analysis Report by Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy), by Indication (B-cell Malignancies, Prostate Cancer), by End-use, by Region, and Segment Forecasts, 2022-2030 - Product Thumbnail Image

Cellular Immunotherapy Market Size, Share & Trends Analysis Report by Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy), by Indication (B-cell Malignancies, Prostate Cancer), by End-use, by Region, and Segment Forecasts, 2022-2030

  • Report
  • July 2022
  • 165 Pages
  • Global
From
CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Biospecific Antibody Market Analysis & Forecast to 2023-2033: Market By Drug Type; By Indication; By Distribution Channel; and by Region - Product Thumbnail Image

Biospecific Antibody Market Analysis & Forecast to 2023-2033: Market By Drug Type; By Indication; By Distribution Channel; and by Region

  • Report
  • July 2023
  • 145 Pages
  • Global
From
Spain CAR-T Cell Therapy Market, By Region, Competition, Forecast & Opportunities, 2019-2029F - Product Thumbnail Image

Spain CAR-T Cell Therapy Market, By Region, Competition, Forecast & Opportunities, 2019-2029F

  • Report
  • October 2024
  • 87 Pages
  • Spain
From
Germany CAR-T Cell Therapy Market, By Region, Competition, Forecast and Opportunities, 2018-2028F - Product Thumbnail Image

Germany CAR-T Cell Therapy Market, By Region, Competition, Forecast and Opportunities, 2018-2028F

  • Report
  • November 2023
  • 81 Pages
  • Germany
From
France CAR-T Cell Therapy Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

France CAR-T Cell Therapy Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 90 Pages
  • France
From
Japan CAR-T Cell Therapy Market, Competition, Forecast & Opportunities, 2028 - Product Thumbnail Image

Japan CAR-T Cell Therapy Market, Competition, Forecast & Opportunities, 2028

  • Report
  • October 2023
  • 81 Pages
  • Japan
From
Loading Indicator

The B Cell Maturation Antigen (BCMA) market is a subset of the oncology drugs market. BCMA is a protein found on the surface of B cells, a type of white blood cell. BCMA is a promising target for cancer immunotherapy, as it is expressed on multiple myeloma cells and other B-cell malignancies. BCMA-targeted therapies are designed to stimulate the body's immune system to recognize and attack cancer cells. BCMA-targeted therapies are being developed by a number of companies, including Amgen, Bristol-Myers Squibb, Celgene, Gilead Sciences, and Novartis. These companies are researching and developing BCMA-targeted therapies for multiple myeloma and other B-cell malignancies. Additionally, several clinical trials are underway to evaluate the safety and efficacy of BCMA-targeted therapies. Show Less Read more